Skip to content

Disc Medicine IRON Ratios & Valuation

FY'25FY'24FY'23FY'22
Returns
Return on equity-35.9%-8.1pp-27.7%+1.6pp-29.3%
Return on assets-32.6%-7.3pp-25.3%+1.6pp-26.9%+5.1pp-32%
Return on invested capital-49.1%
Liquidity
Current ratio21.9×+0.8×21.2×+4.1×17.1×+8.3×8.8×+2.1×
Quick ratio21.9×+0.8×21.2×+4.1×17.1×+8.3×8.8×+2.1×
Cash ratio2.5×-5.8×8.3×-8.6×16.8×+8.2×8.6×+2.1×
Leverage
Debt-to-equity0.0×0.1×+0.1×0.0×
Debt-to-assets0.0×0.1×+0.1×0.0×0.0×
Interest coverage-65.4×+161×-226.8×
Per Share
Book value per share$20.96+30.4%$16.07+3.9%$15.47-90.9%$169.89+332%
Valuation
Market capitalization$3B+58.9%$1.89B+38.6%$1.36B+5,053%$26.41M-84.2%
Enterprise value$2.94B+70.4%$1.72B+72.0%$1B+701%-$166.86M-311%
Price / book4.1×-0.2×4.3×+0.3×3.9×+3.8×0.1×
Free cash flow yield-6%-1.0pp-5%+0.4pp-5.4%+155pp-160.5%
Earnings yield-7.1%-1.3pp-5.8%-0.2pp-5.6%+172pp-177.3%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

Where do Disc Medicine's ratios come from?
Every ratio is computed from Disc Medicine's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.